• 1
    Loftus EV, Silverstein MD, Sandborn WJ, Tremain WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: Incidence, Prevalence and Survival. Gastroenterology 1998; 114: 11611168.
  • 2
    Nunes GC, Ahlquist Jr RE. Increasing incidence of Crohn’s disease. American Journal of Surgery 1983; 145(5): 57881.
  • 3
    Calkins BM, Lilienfeld AM, Garland CF, Mendeloff AI. Trends in incidence rates of ulcerative colitis and Crohn’s disease. Digestive Diseases & Sciences 1984; 29(10): 91320.
  • 4
    Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi AG, D’Albasio G, Galli M, Vannozzi G, Milla M, Tarantino O, Renai F, Messori A, Amorosi A, Pacini F, Morettini A. A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol 1996; 31(9): 8929.
  • 5
    Thomas GA, Millar-Jones D, Rhodes J, Roberts GM, Williams GT, Mayberry JF. Incidence of Crohn’s disease in Cardiff over 60 years: 1986–1990 an update. Eur J Gastroenterol Hepatol 1995; 7(5): 4015.
  • 6
    Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn’s disease. Gut 1989; 30(5): 61822.
  • 7
    Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Alim Pharmacol Therapeut 2000; 14(12): 15539.
  • 8
    Loftus Jr EF, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review. Alim Pharmacol Therapeut 2002; 16(1): 5160.
  • 9
    Prior P, Fielding JF, Waterhouse JA, Cooke WT. Mortality in Crohn’s disease. Lancet 1970; 1: 11357.
  • 10
    Probert CSJ, Jayanthi V, Wicks ACB, Mayberry JF. Mortality in Crohn’s disease in Leicestershire, 1972–1989: an epidemiological community based study. Gut 1992; 33: 122628.
  • 11
    Weterman IT, Biermond I, Pena AS. Mortality and causes of death in Crohn’s disease. Review of 50 years’ experience in Leiden University Hospital. Gut 1990; 31: 138790.
  • 12
    Plumley PW. The impact of demographic trends on financial security systems. Employee Benefits J. 1978; 3(4): 49.
  • 13
    Travis SPL. Insurance risks for patients with ulcerative colitis or Crohn’s disease. Alim Pharmacol Therepeut 1997; 11: 519.
  • 14
    Moody GA, Mayberry JF. Life insurance and inflammatory bowel disease: Is there discrimination against patients? Int J Colorectal Dis 1996; 11: 2768.
  • 15
    Harris PR, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Methods Work Group for the US Preventive Services Task Force. Criteria for grading individual studies and linkages in the analytic framework. J Prevent Med 2001; 20(3S): 2135.
  • 16
    Sharpe SJ. Meta-analysis regression. Stata Tech Bull 1998; 42: 1622.
  • 17
    Sharpe SJ, Sterne JAC. Meta-analysis. Stata Tech Bull. 1997; 38: 914.
  • 18
    Stata Statistical Software. [computer program] Stata Corp. College Station. Texas: Stata Corporation; 1997.
  • 19
    Sutton AJ, Abrams KR, Jones DR. An illustrated guide to the methods of meta-analysis. J Eval Clin Practice 2001; 7(2): 13548.
  • 20
    Cottone M, Magliocco A, Rosselli M, Pinzone F, Oliva L, Orlando A, Aiala MR, Cipolla C, Pagliaro L. Mortality in patients with Crohn’s disease. Scand J Gastroenterol 1996; 31: 3725.
  • 21
    Farrokhyar F, Swarbrik ET, Grace RH, Hellier MD, Gent AE, Irvine EJ. Low mortality in ulcerative colitis and Crohn’s disease in three regional centres in England. Am J Gastroenterol 2001; 96(2): 5017.
    Direct Link:
  • 22
    Mayberry JF, Dew MJ, Morris JS, Powell DB. An audit of Crohn’s disease in a defined population. J Roy College Physicians London 1983; 17: 1968.
  • 23
    Uno H, Yao T, Matsui T, Sakurai T, Iida M, Matsumoto T, Aoyagi K, Fuchigami T. Mortality and cause of death in Japanese patients with Crohn’s disease. Dis Colon Rectum 2003; 46(10 Suppl): S1521.
  • 24
    Card T, Hubbard R, Cogan RF. Mortality in inflammatory bowel disease: a population based cohort study. Gastroenterology 2003; 125(6): 158390.
  • 25
    Persson P, Bernell O, Leijonmarck C, Farahmand BY, Hellers G, Ahlbom A. Servival and cause-specific mortality in inflammatory bowel disease. Gastroenterology 1996; 110: 133945.
  • 26
    Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population based study. Gastroenterology 1992; 103: 95460.
  • 27
    Irvine EJ. Quality of life assessment: impact on patient management. In: RamptonD ed. Inflammatory Bowel Disease – Clinical Diagnosis and Management. London: Martin Dunitz, 2000: 23551.
  • 28
    Stenson WF, Korzenik J. Inflammatory bowel disease. In: YamandaT, AlpersD, KaplowitzN, LourieL, OwyangC, Powell DW eds. Textbook of GastroenterologyVolume 2 4th Ed. Philedelphia, USA: Lippincott, Williams and Wilkins, 2003: 16991759.
  • 29
    Canavan C, Abrams KR, Hawthorne B, Mayberry JF. Long-term prognosis in Crohn’s disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Alim Pharmacol Therapeut 2007; 25(1): 5965.
  • 30
    Government Actuary’s Department. Period and cohort life expectancies for males and females, 1981 to 2053. September2003.
  • 31
    Probert CSJ, Jayanthi V, Bhakta P, Wicks ACB, Mayberry JF. How necessary is colostomy? An epidemiological study of the surgical management of ulcerative colitis amongst different ethnic groups in Leicestershire. Eur J Gastroenterol Hepatol 1993; 5: 1720.
  • 32
    Mayberry JF, Newcombe RG, Rhodes J. Mortality in Crohn’s disease. Quart J Med 1980; 193: 638.
  • 33
    Jess T, Winther VK, Munkholm P, Langholz E, Binder V. Mortality and causes of death in Crohn’s disease: follow up of a population based cohort in Copenhagen County, Denmark. Gastroenterology 2002; 122: 180814.
  • 34
    Wolters FL, Russel M, Stockbrugger RW. Systematic review: has disease outcome in Crohn’s disease changed during the last for decades? Alim Pharmacol Therapeut 2004; 20: 48396.
  • 35
    Morrison BC, Lockhart-Mummary HE. Crohn’s disease of the colon. Gastroenterologica 1959; 92: 16873.
  • 36
    Demole M, Sayegh C, Soualili EH. Therapeutic possibilities and results in regional ileitis. Praxis 1965; 54(47): 14026.
  • 37
    Jones JH, Lennard-Jones JE. Corticosteroids and corticotrophin in the treatment of Crohn’s disease. Gut 1966; 7(2): 1817.
  • 38
    Brooke BN, Hoffmann DC, Swarbrick ET. Azathioprine for Crohn’s disease. Lancet 1969; 2(7621): 6124.
  • 39
    Van Dullerman HM, Van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, Woody J. Treatment of Crohn’s disease with anti-tumor necrosis factor chimeric monoclonal antibody. Gastroenterology 1995; 109(1): 12935.
  • 40
    National Institute of Clinical Excellence. Guidance on use of infliximab in Crohn’s disease. London 2002.
  • 41
    Prior P, Gyde S, Cooke WT, Waterhouse JAH, Allen RN. Mortality in Crohn’s disease. Gastroenterology 1981; 80: 30712.
  • 42
    Casellas F, Lopez-Vivancos, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001; 13: 56772.
  • 43
    Masala G, Bagnoli S, Ceroti M, Saieva C, Trallori G, Zanna I, D’Albasio G, Palli D. Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001. Gut 2004; 53(9): 130913.
  • 44
    Palli D, Masala G, Trallori G, Bardazzi G, Saieva C. A capture-recapture estimate of inflammatory bowel disease prevalence: the Florence population-based study. Italian J Gastroenterol Hepatol 1998; 30(1): 503.
  • 45
    Jacobsson LT, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, Del Puente A, McCance DR, Charles MA, Bennett PH. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum 1993; 36(8): 104553.
  • 46
    Noale M, Minicuci N, Bardage C, Gindin J, Nikula S, Pluijm S, Rodriguez-Laso A, Maggi S. Predictors of mortality: an international comparison of socio-demographic and health characteristics from six longitudinal studies on aging: the CLESA project. Exp Gerontol 2005; 2: 8999.
  • 47
    Vessey M, Painter R, Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 2003; 362(9379): 18591.
  • 48
    Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004; 328(7455): 1519.
  • 49
    Sly RM, O’Donnell R. Stabilization of asthma mortality. Ann Allergy, Asthma, Immunol 1997; 78(4): 34754.
  • 50
    West J, Logan RF, Smith CJ, Hubbard RB, Card TR. Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ. 2004; 329(7468): 7169.
  • 51
    Loftus Jr EV, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gut 2000; 46(3): 33643.
  • 52
    Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993. Diabetes Care 1998; 21(7): 113845.